Riccardo Autorino

Riccardo Autorino, MD, PhD, is a Professor in the Department of Urology at Rush Medical College, Rush University. As Director of Surgical Innovation and Clinical Research, he specializes in robotic urologic surgery, oncology, and minimally invasive techniques. His research focuses on kidney and prostate cancers, surgical outcomes, and innovative technologies like single-port robotic surgery. He has published extensively on topics such as robotic partial nephrectomy, adjuvant therapies, and clinical decision-making models (e.g., nomograms for survival prediction). His work also addresses Peyronie’s disease, erectile dysfunction, and the impact of metabolic factors on urological health.

• Education: MD and PhD degrees (not further specified in text).
• Affiliations: Rush Medical College, ROSULA and ROBUUST Collaborative Groups.

His research interests include:

• Prognostic biomarkers in renal cell carcinoma and urothelial cancers.
• Advancing robotic surgery techniques for kidney and prostate procedures.
• Optimizing postoperative outcomes through surgical innovation.
• Evaluating adjuvant therapies for high-risk cancers.

Key Articles Trends (2025): Focus on robotic partial nephrectomy efficacy, adjuvant immunotherapy for upper tract urothelial carcinoma, and nomograms for predicting survival. Studies emphasize collaborative research, multicenter analyses, and machine learning applications for diagnostic prediction.

Grants & Advising: No specific grants listed, but leads collaborative groups like ROBUUST. No students explicitly mentioned in text.

Labs/Teams: Surgical Innovation Program at Rush University, focusing on single-port robotic techniques and clinical research initiatives.